CinCor Pharma, Inc.
CINC · NASDAQ
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,339 | $710 | $586 | $567 |
| - Cash | $293 | $128 | $165 | $137 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1,047 | $583 | $422 | $430 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$20 | -$21 | -$14 | -$29 |
| % Margin | – | – | – | – |
| Net Income | -$20 | -$21 | -$20 | -$33 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.48 | -0.54 | -0.59 | -0.94 |
| % Growth | 11.1% | 8.5% | 37.2% | – |
| Operating Cash Flow | -$15 | -$20 | -$18 | -$11 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$15 | -$20 | -$18 | -$11 |